Barr Adds Preven To OTC Contraceptive Pipeline
This article was originally published in The Tan Sheet
Executive Summary
Barr's acquisition of rights to emergency contraceptive Preven from Gynetics gives the firm another potential Rx-to-OTC switch candidate